The biopharmaceutical company will allow the US government to utilise its stocks of remdesivir, following the FDA’s approval to use the drug to treat COVID-19 cases.
CEO Today Online and CEO Today magazine are dedicated to providing CEOs and C-level executives with the latest corporate developments, business news and technological innovations.
